Approval · Notice of Compliance 38197 · 2026
BOSAYA: Notice of Compliance 38197
Issued August 28, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38197
- Date
- August 28, 2026
- Company
- Biocon Biologics Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOSAYA | Not yet assigned | — |
Medicinal ingredients
- DENOSUMAB 60 MG per ML